(19)
(11) EP 3 864 038 A1

(12)

(43) Date of publication:
18.08.2021 Bulletin 2021/33

(21) Application number: 19795043.9

(22) Date of filing: 08.10.2019
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
(86) International application number:
PCT/GB2019/052842
(87) International publication number:
WO 2020/074874 (16.04.2020 Gazette 2020/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.10.2018 GB 201816442

(71) Applicant: Genome Research Limited
London NW1 2BE (GB)

(72) Inventors:
  • BRADLEY, Allan
    Cambridge, Cambridgeshire CB10 1SA (GB)
  • MARTIN, Jolyon Nicolas Edouard
    Cambridge, Cambridgeshire CB10 1SA (GB)

(74) Representative: CMS Cameron McKenna Nabarro Olswang LLP 
Cannon Place 78 Cannon Street
London EC4N 6AF
London EC4N 6AF (GB)

   


(54) ANIMAL MODELS AND THERAPEUTIC MOLECULES